SEREVENT Inhalation Aerosol is supplied in 13-g canisters containing 120 metered actuations in boxes of 1. Each actuation delivers 25 mcg of salmeterol base (as salmeterol xinafoate) from the valve and 21 mcg of salmeterol base (as salmeterol xinafoate) from the actuator. Each canister is supplied with a green plastic actuator with a teal strapcap and patient's instructions (NDC 0173-0464-00). Also available, SEREVENT Inhalation Aerosol Refill (NDC 0173-0465-00), a 13-g canister only with patient’s instructions.
SEREVENT Inhalation Aerosol is also supplied in institutional packs that consist of a 6.5-g canister containing 60 metered actuations in boxes of 1. Each actuation delivers 25 mcg of salmeterol base (as salmeterol xinafoate) from the valve and 21 mcg of salmeterol base from the actuator (as salmeterol xinafoate). Each canister is supplied with a green plastic actuator with a teal strapcap and patient's instructions (NDC 0173-0467-00).
For use with SEREVENT Inhalation Aerosol actuator only. The green actuator with SEREVENT Inhalation Aerosol should not be used with other aerosol medications, and actuators from other aerosol medications should not be used with a SEREVENT Inhalation Aerosol canister.
The correct amount of medication in each inhalation cannot be assured after 120 actuations from the 13-g canister or 60 actuations from the 6.5-g canister even though the canister is not completely empty. The canister should be discarded when the labeled number of actuations has been used.
Store between 15° and 30°C (59° and 86°F). Store canister with nozzle end down. Protect from freezing temperatures and direct sunlight.
Avoid spraying in eyes. Contents under pressure. Do not puncture or incinerate. Do not store at temperatures above 120°F. Keep out of reach of children. As with most inhaled medications in aerosol canisters, the therapeutic effect of this medication may decrease when the canister is cold; for best results, the canister should be at room temperature before use. Shake well before using.
Note: The indented statement below is required by the Federal government’s Clean Air Act for all products containing or manufactured with chlorofluorocarbons (CFCs).
WARNING: Contains trichlorofluoromethane and dichlorodifluoromethane, substances that harm public health and environment by destroying ozone in the upper atmosphere.
A notice similar to the above WARNING has been placed in the patient information leaflet of this product pursuant to EPA regulations. The patient’s warning states that the patient should consult his or her physician if there are questions about alternatives.
Research Triangle Park, NC 27709
©2004, GlaxoSmithKline. All rights reserved.